Literature DB >> 3326893

Factitious hyperinsulinemic hypoglycemia: confirmation of the diagnosis by a species-specific insulin radioimmunoassay.

P G Walfish1, D S Feig, W A Bauman.   

Abstract

Surreptitious self-administration of insulin is an important cause of hypoglycemia. A 28-year-old female hospital ward clerk presented with hypoglycemia associated with an elevated plasma insulin level and a low plasma C-peptide concentration. Factitious illness was denied by the patient until it was definitively proven by using a species-specific insulin radioimmunoassay that the type of insulin circulating at the time of hypoglycemia was of animal rather than of human origin. The differential diagnosis of hypoglycemia associated with hyperinsulinemia and the current laboratory methods which may be employed to distinguish between factitious hypoglycemia and endogenous hyperinsulinism are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3326893     DOI: 10.1007/BF03347007

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  7 in total

1.  Differential diagnosis between endogenous and exogenous insulin-induced refractory hypoglycemia in a nondiabetic patient.

Authors:  W A Bauman; R S Yalow
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

2.  High performance liquid chromatography used to distinguish the autoimmune hypoglycemia syndrome from factitious hypoglycemia.

Authors:  R F Klein; S Seino; N Sanz; M S Nolte; A I Vinik; J H Karam
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

3.  Hyperinsulinemic hypoglycemia. Differential diagnosis by determination of the species of circulating insulin.

Authors:  W A Bauman; R S Yalow
Journal:  JAMA       Date:  1984-11-16       Impact factor: 56.272

4.  Sulfonylurea-induced factitious hypoglycemia in a nondiabetic nurse.

Authors:  P G Walfish; R P Kashyap; S Greenstein
Journal:  Can Med Assoc J       Date:  1975-01-11       Impact factor: 8.262

5.  Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies.

Authors:  J A Scarlett; M E Mako; A H Rubenstein; P M Blix; J Goldman; D L Horwitz; H Tager; J B Jaspan; M R Stjernholm; J M Olefsky
Journal:  N Engl J Med       Date:  1977-11-10       Impact factor: 91.245

6.  Factitious disorders in a teaching hospital.

Authors:  P Reich; L A Gottfried
Journal:  Ann Intern Med       Date:  1983-08       Impact factor: 25.391

7.  Insulin antibodies in insulin-dependent diabetics before insulin treatment.

Authors:  J P Palmer; C M Asplin; P Clemons; K Lyen; O Tatpati; P K Raghu; T L Paquette
Journal:  Science       Date:  1983-12-23       Impact factor: 47.728

  7 in total
  3 in total

Review 1.  Disorders of glucose metabolism-post mortem analyses in forensic cases: part I.

Authors:  Cornelius Hess; Frank Musshoff; Burkhard Madea
Journal:  Int J Legal Med       Date:  2010-09-29       Impact factor: 2.686

Review 2.  Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.

Authors:  Lindsey J Anderson; Jamie M Tamayose; Jose M Garcia
Journal:  Mol Cell Endocrinol       Date:  2017-06-09       Impact factor: 4.102

Review 3.  Advances in the diagnosis and management of hyperinsulinemic hypoglycemia.

Authors:  Ritika R Kapoor; Chela James; Khalid Hussain
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.